Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Severe Intestinal Polyposis in FAP
NCT03095703Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in familial adenomatous polyposis (FAP), sponsored by University of Amsterdam. Started Oct 2017; status: completed.
02
Drugs
sirolimus
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT03095703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03095703.